 |
|
Research Probes Details of Poor Adherence in Antihypertensive Drug Therapy
Mike Mitka
JAMA. 2007;298(18):2128.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
A unique data set is providing researchers with some cluesinto the murky realm of medication adherence for patients who have hypertension.
Controlling hypertension can be a difficult task and increases the risk for cardiovascular mortality and morbidity. It is estimated that only 30% of patients treated for hypertension achieve their target blood pressure goals. For physicians, the question becomes: are these patients not responding to the initial therapy, or are they not taking their medications in the prescribed manner?
At the European Society of Cardiology Congress on September 1 in Vienna, Austria, Bernard Vrijens, MD, chief scientist with AARDEX Group's research and development center in Visé, Belgium, described a study based on a review of the company's electronically recorded drug dosing histories of 4783 patients prescribed once-daily antihypertensive drug therapy. The data showed that half the patients had stopped their treatment within 1 year and that 50% of . . . [Full Text of this Article]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster Randomized, Controlled Trial
Feldman et al.
Hypertension 2009;53:646-653.
ABSTRACT
| FULL TEXT
Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale)
Thilly et al.
Nephrol Dial Transplant 2009;24:934-939.
ABSTRACT
| FULL TEXT
|
